Filing metadata

Accession number
0001214659-22-013304
Form type
Form 3
Filer
Mirati Therapeutics, Inc.
CIK
CIK 1576263
Filed
Nov 08, 2022
Reporting period
Nov 07, 2022
Description
Initial ownership

Explore SEC Filings Hub